Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

SUMOylation Regulator-Related Molecules Can Be Used as Prognostic Biomarkers for Glioblastoma

9 Apr 2021

Abstract excerpt

INTRODUCTION: SUMOylation is one of the post-translational modifications. The relationship between the expression of SUMOylation regulators and the prognosis of glioblastoma is not quite clear. MATERIALS AND METHODS: The single nucleotide variant data, the transcriptome data, and survival information were acquired from The Cancer Genome Atlas, Gene Expression Omnibus, and cBioportal database. Wilcoxon test was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 14-3-3 protein interactions
Share to Sirtuins and Resveratrol in Medicine
Share to Ubiquitin and proteasome pathways

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33898460
DOI: 10.3389/fcell.2021.658856

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SUMOylation Regulator-Related Molecules Can Be Used as Prognostic Biomarkers for GlioblastomaPMID 33898460Read ↗

Identification of novel genes associated with diagnosis and prognosis in glioblastomaSemantic proximity Read ↗

WITHDRAWN: Identification of SUMOylation biomarkers in glioblastoma based on transcriptome and Mendelian randomization combined with single-cell RNA-seq analysisSemantic proximity Read ↗

Identification of Potential Key Genes Associated with the Pathogenesis and Prognosis of Glioblastoma Based on Integrated Bioinformatics AnalysisSemantic proximity Read ↗

Identification of an Immune-Related Prognostic Risk Model in GlioblastomaSemantic proximity Read ↗

Identification of Crucial Candidate Genes and Pathways in Glioblastoma Multiform by Bioinformatics AnalysisSemantic proximity Read ↗

Identification of Immune-Related lncRNA Prognostic Signature and Molecular Subtypes for GlioblastomaSemantic proximity Read ↗

A Novel 16-Genes Signature Scoring System as Prognostic Model to Evaluate Survival Risk in Patients with GlioblastomaSemantic proximity Read ↗

Identification of a Specific Gene Module for Predicting Prognosis in Glioblastoma PatientsSemantic proximity Read ↗

Identification of Candidate Genes Associated With Prognosis in GlioblastomaSemantic proximity Read ↗

A Novel Six-mRNA Signature Predicts Survival of Patients With Glioblastoma MultiformeSemantic proximity Read ↗

Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastomaSemantic proximity Read ↗

Identification of novel prognostic targets in glioblastoma using bioinformatics analysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.